A panel of ovarian cancer cell lines, characterized for RNASET2 expression levels, is available in our laboratory and will be used to investigate the relationship between RNASET2 levels, expression of these three genes and putative phenotypic outcomes. The gene discussed is RNASET2; the disease is ovarian carcinoma.